Communiqués InspireMD, Inc.

Actions

NSPR

US45779A8466

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq 19:21:18 08/10/2026			Varia. 5j.	Varia. 1 janv.
0,4800 ^USD	-6,61%		-22,53%	-73,03%

17/08	Transcript : InspireMD, Inc., Q2 2026 Earnings Call, Aug 17, 2026
14/08	InspireMD, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

21/09	InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million	AQ
04/09	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
03/09	InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference	AQ
17/08	InspireMD Reports Second Quarter 2026 Financial Results	AQ
10/08	InspireMD to Announce Second Quarter 2026 Financial Results	AQ
07/08	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
30/07	InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing	AQ
15/06	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	AQ
12/06	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
11/06	InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures	AQ
08/06	InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures	AQ
06/05	InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference	AQ
05/05	InspireMD : May 2026 Investor Deck	PU
04/05	InspireMD Reports First Quarter 2026 Financial Results	AQ
04/05	InspireMD Initiates Voluntary U.S. Recall of CGuard Prime 135 cm Carotid Stent Delivery System	AQ
01/05	InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System	AQ
01/05	InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System	AQ
27/04	InspireMD to Announce First Quarter 2026 Financial Results	AQ
14/04	InspireMD : April 2026 Investor Deck	PU
31/03	InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference	AQ
18/03	InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
09/03	InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results	AQ
05/03	InspireMD : March 2026 Investor Deck	PU
20/01	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
12/01	InspireMD : January 2026 Investor Deck	PU